nach oben

Strahlentherapie und Onkologie

Erschienen in:

01.07.2012 | Original article

Intra- and intertumor heterogeneities in total, chronic, and acute hypoxia in xenografted squamous cell carcinomas

Detection and quantification using (immuno-)fluorescence techniques

verfasst von: C.-A. Maftei, C. Bayer, Ph.D., K. Shi, P. Vaupel

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 7/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Heterogeneously distributed hypoxia is a major characteristic of solid tumors. (Immuno-)fluorescence detection of hypoxia in experimental tumors is frequently assessed in a single central section; however, this may not necessarily be representative of the whole tumor. In order to determine whether analysis of one central section is exemplary of the whole tumor and whether different volumes have an impact on tumor oxygenation, we assessed the fractions of total (TH), chronic (CH), and acute hypoxia (AH) throughout different layers of tumors of varying volumes.

Materials and methods

Xenografted FaDu human squamous cell carcinomas of different volumes were investigated for intra- and intertumor heterogeneities. Tissue blocks located at the apical, central, and basal layer were sliced from individual tumors. Four serial cryosections were analyzed from each tissue block. Vital tumor tissue was explored for the distribution of Hoechst 33342 (perfusion), pimonidazole (hypoxia), and CD31 (endothelium) to assess TH, CH, and AH.

Results

Fractions of TH, CH, and AH were consistently similar in the serial sections of individual tissue blocks. However, significant differences were found between the apical, central, and basal blocks that were even opposite depending on the tumor volume. Pooled data from all three tissue blocks revealed significantly higher fractions of hypoxia in the large tumors than in the small tumors.

Conclusion

FaDu tumors exhibit a heterogeneous and volume-dependent oxygenation status. Assessing the average fractions of TH, CH, and AH from central blocks corresponds best to the average of the entire tumor. However, information on intratumor heterogeneities is lost, especially when considering tumors of substantially different volumes.

Arabi M, Piert M (2010) Hypoxia PET/CT imaging: implications for radiation oncology. QJ Nucl Med Mol Imaging 54:500–509

Arteel GE, Thurman RG, Yates JM, Raleigh JA (1995) Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver. Br J Cancer 72:889–895PubMedCrossRef

Astner ST, Shi K, Vaupel P, Molls M (2010) Imaging of tumor physiology: impacts on clinical radiation oncology. Exp Oncol 32:149–152PubMed

Bache M, Kappler M, Said HM et al (2008) Detection and specific targeting of hypoxic regions within solid tumors: current preclinical and clinical strategies. Curr Med Chem 15:322–338PubMedCrossRef

Bayer C, Maftei CA, Astner ST et al (2010) Subtypes of chronic and acute hypoxia in tumors according to different causative mechanisms. Strahlenther Onkol 186(Suppl 1):66

Bayer C, Shi K, Astner ST et al (2011) Acute versus chronic hypoxia: why a simplified classification is simply not enough. Int J Radiat Oncol Biol Phys 80:965–968PubMedCrossRef

Bayer C, Shi K, Maftei C et al (2011) Assessment of chronic and acute hypoxia in head and neck cancer using microscopic and macroscopic imaging approaches. Strahlenther Onkol 187:602

Brown JM (1979) Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br J Radiol 52:650–656PubMedCrossRef

Busk M, Horsman MR, Jakobsen S et al (2009) Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast? Radiother Oncol 92:429–436PubMedCrossRef

10.

Chaplin DJ, Durand RE, Olive PL (1986) Acute hypoxia in tumors: implications for modifiers of radiation effects. Int J Radiat Oncol Biol Phys 12:1279–1282PubMedCrossRef

11.

Chitneni SK, Palmer GM, Zalutsky MR, Dewhirst MW (2011) Molecular imaging of hypoxia. J Nucl Med 52:165–168PubMedCrossRef

12.

Grosu AL, Souvatzoglou M, Röper B et al (2007) Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer. Int J Radiat Oncol Biol Phys 69:541–551PubMedCrossRef

13.

Höckel M, Schlenger K, Knoop C, Vaupel P (1991) Oxygenation of carcinomas of the uterine cervix: evaluation by computerized O₂ tension measurements. Cancer Res 51:6098–6102PubMed

14.

Ljungkvist AS, Bussink J, Rijken PF et al (2002) Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 54:215–228PubMedCrossRef

15.

Maftei CA, Bayer C, Astner ST et al (2011) Monitoring the fraction of total hypoxia and hypoxia subtypes in human squamous cell carcinomas during fractionated irradiation: evaluation using pattern recognition in microcirculatory supply units. Strahlenther Onkol 187(Suppl 1):25CrossRef

16.

Maftei CA, Bayer C, Shi K et al (2011) Quantitative assessment of hypoxia subtypes in microcirculatory supply units of malignant tumors using (immuno-)fluorescence techniques. Strahlenther Onkol 187:260–266PubMedCrossRef

17.

Maftei CA, Bayer C, Shi K et al (2011) Changes in the fraction of total hypoxia and hypoxia subtypes in human squamous cell carcinomas upon fractionated irradiation: evaluation using pattern recognition in microcirculatory supply units. Radiother Oncol 101:209–216PubMedCrossRef

18.

Maftei CA, Shi K, Bayer C et al (2011) Comparison of (immuno-) fluorescence data with serial [¹⁸F]Fmiso PET/CT imaging for assessment of chronic and acute hypoxia in head and neck cancers. Radiother Oncol 99:412–417PubMedCrossRef

19.

Magat J, Jordan BF, Cron GO, Gallez B (2010) Noninvasive mapping of spontaneous fluctuations in tumor oxygenation using ¹⁹F MRI. Med Phys 37:5434–5441PubMedCrossRef

20.

Manz R, Otte J, Thews G, Vaupel P (1983) Relationship between size and oxygenation status of malignant tumors. Adv Exp Med Biol 159:391–398PubMed

21.

Mueller-Klieser W, Vaupel P, Manz R, Schmidseder R (1981) Intracapillary oxyhemoglobin saturation of malignant tumors in humans. Int J Radiat Oncol Biol Phys 7:1397–404PubMedCrossRef

22.

Nordsmark M, Bentzen SM, Rudat V et al (2005) Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 77:18–24PubMedCrossRef

23.

Reinhold HS, Blachiwiecz B, Blok A (1977) Oxygenation and reoxygenation in “sandwich” tumours. Bibl Anat 15:270–272PubMed

24.

Rofstad EK, Maseide K (1999) Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumors. Int J Radiat Biol 75:1377–1393PubMedCrossRef

25.

Stadler P, Becker A, Feldmann HJ et al (1999) Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. Int J Radiat Oncol Biol Phys 44:749–754PubMedCrossRef

26.

Tatum J, Kelloff GJ, Gillies RJ et al (2006) Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol 82:699–757PubMedCrossRef

27.

Thomlinson RH, Gray l (1955) The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 9:539–549PubMedCrossRef

28.

Vaupel P (1977) Hypoxia in neoplastic tissue. Microvasc Res 13:399–408PubMedCrossRef

29.

Vaupel P (2004) The role of hypoxia-induced factors in tumor progression. Oncologist 9(Suppl 5):10–17PubMedCrossRef

30.

Vaupel P (2009) Physiological mechanisms of treatment resistance. In: Molls M, Vaupel P, Nieder C et al (eds) The impact of tumor biology on cancer treatment and multidisciplinary strategies. Springer, Berlin-Heidelberg, pp 273–290

31.

Vaupel P (2011) Acute and chronic hypoxia in the clinical setting: merely an academic discussion or do we need to distinguish between the two? Strahlenther Onkol 187:601

32.

Vaupel P, Harrison L (2004) Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. Oncologist 9(Suppl 5):4–9PubMedCrossRef

33.

Vaupel P, Mayer A (2007) Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 26:225–239PubMedCrossRef

34.

Vaupel P, Mueller-Klieser W (1986) Cell line and growth site as relevant parameters governing tumor tissue oxygenation. Adv Exp Med Biol 200:633–643PubMedCrossRef

35.

Vaupel PW, Frinak S, Bicher HI (1981) Heterogeneous oxygen partial pressure and pH distribution in C3H mouse mammary adenocarcinoma. Cancer Res 41:2008–2013PubMed

36.

Vaupel P, Höckel M, Mayer A (2007) Detection and characterization of tumor hypoxia using pO₂ histography. Antioxid Redox Signal 9:1221–1235PubMedCrossRef

37.

Vaupel P, Kluge M, Ambroz MC (1988) Laser Doppler flowmetry in subepidermal tumours and in normal skin of rats during localized ultrasound hyperthermia. Int J Hyperthermia 4:307–321PubMedCrossRef

38.

Vaupel P, Fortmeyer HP, Runkel S, Kallinowski F (1987) Blood flow, oxygen consumption, and tissue oxygenation of human breast cancer xenografts in nude rats. Cancer Res 47:3496–503PubMed

39.

Vaupel P, Schlenger K, Knoop C, Höckel M (1991) Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O₂ tension measurements. Cancer Res 51:3316–3322PubMed

40.

Wendling P, Manz R, Thews G, Vaupel P (1984) Heterogeneous oxygenation of rectal carcinomas in humans: a critical parameter for preoperative irradiation? Adv Exp Med Biol 180:293–300PubMed

41.

Yaromina A, Hölscher T, Eicheler W et al (2005) Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma? Radiother Oncol 76:206–212PubMedCrossRef

42.

Yaromina A, Zips D, Thames HD et al (2006) Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies. Radiother Oncol 81:122–129PubMedCrossRef

43.

Yasui H, Matsumoto S, Devasahayam N et al (2010) Low-field magnetic resonance imaging to visualize chronic and cycling hypoxia in tumor-bearing mice. Cancer Res 70:6427–6436PubMedCrossRef

44.

Wang K, Yorke E, Nehmeh SA et al (2009) Modeling acute and chronic hypoxia using serial images of ¹⁸F-FMISO PET. Med Phys 36:4400–4408PubMedCrossRef

45.

Zoula S, Rijken PF, Peters JP et al (2003) Pimonidazole binding in C6 rat brain glioma: relation with lipid droplet detection. Br J Cancer 88:1439–1444PubMedCrossRef

Titel: Intra- and intertumor heterogeneities in total, chronic, and acute hypoxia in xenografted squamous cell carcinomas
Detection and quantification using (immuno-)fluorescence techniques
verfasst von: C.-A. Maftei
C. Bayer, Ph.D.
K. Shi
P. Vaupel
Publikationsdatum: 01.07.2012
Verlag: Springer-Verlag
Erschienen in: Strahlentherapie und Onkologie / Ausgabe 7/2012
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-012-0105-4

Springer Medizin

Intra- and intertumor heterogeneities in total, chronic, and acute hypoxia in xenografted squamous cell carcinomas

Detection and quantification using (immuno-)fluorescence techniques

Abstract

Background

Materials and methods

Results

Conclusion

Neu im Fachgebiet Onkologie

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

Alter verschlechtert Prognose bei Endometriumkarzinom

Darf man die Behandlung eines Neonazis ablehnen?

Update Onkologie

Springer Medizin

Abstract

Background

Materials and methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2012

Totale mesorektale Exzision mit und ohne präoperative Strahlentherapie bei Patienten mit resektablem Rektumkarzinom

Dosimetric comparison of free-breathing and deep inspiration breath-hold radiotherapy for lung cancer

Respiratory gated [18F]FDG PET/CT for target volume delineation in stereotactic radiation treatment of liver metastases

Strahlentherapie und Rebestrahlung von Mammakarzinompatientinnen mit Hirnmetastasen

Rechtliche Grundlagen für den Umgang mit sicherheitsrelevanten Ereignissen in der Strahlentherapie

Comparison between Acuros XB and Brainlab Monte Carlo algorithms for photon dose calculation

Neu im Fachgebiet Onkologie

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

Alter verschlechtert Prognose bei Endometriumkarzinom

Darf man die Behandlung eines Neonazis ablehnen?

Update Onkologie